• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷治疗室上性心动过速:5年经验(2002 - 2006年)

Adenosine in the treatment of supraventricular tachycardia: 5 years of experience (2002-2006).

作者信息

Riccardi Alessandro, Arboscello Eleonora, Ghinatti Maria, Minuto Pierangela, Lerza Roberto

机构信息

Dipartimento di Emergenza, Pronto Soccorso, Ospedale San Paolo, 17100 Savona, Italy.

出版信息

Am J Emerg Med. 2008 Oct;26(8):879-82. doi: 10.1016/j.ajem.2007.11.029.

DOI:10.1016/j.ajem.2007.11.029
PMID:18926344
Abstract

We report a retrospective analysis of 5 years of adenosine use in our emergency department (2002-2006). We treated 454 patients with an intravenous bolus of adenosine. The cohort was made up of 40.7% men and 59.3% women, with mean age of 47.32 years, mean heart rate of 162.48 beats per minute. Among them, 73% responded immediately to the 6-mg dose, 15% responded after the second 12-mg dose, and 11% responded to a further 12-mg dose, whereas 11% were unresponsive. We observed minor side effects in a high percentage of patients (ie, chest tightness 83%, flushing 39.4%, sense of impending death 7%). Only 1 major adverse effect was recorded, that is, administering 12 mg of adenosine induced a marked acceleration in the ventricular rate of a patient with an undiagnosed atrial flutter, caused by induction of atrioventricular conduction (1:1). Our results confirm that when patients are appropriately selected, adenosine is probably the best available drug to treat paroxysmal supraventricular tachycardias, especially in emergency situations.

摘要

我们报告了对我院急诊科5年(2002 - 2006年)使用腺苷情况的回顾性分析。我们对454例患者静脉推注了腺苷。该队列中男性占40.7%,女性占59.3%,平均年龄为47.32岁,平均心率为每分钟162.48次。其中,73%的患者对6毫克剂量立即有反应,15%的患者在第二次给予12毫克剂量后有反应,11%的患者对再一次给予的12毫克剂量有反应,而11%的患者无反应。我们观察到高比例患者出现轻微副作用(即胸闷83%、面部潮红39.4%、濒死感7%)。仅记录到1例严重不良反应,即给予12毫克腺苷导致1例未确诊的心房扑动患者心室率显著加快,这是由房室传导(1:1)诱发的。我们的结果证实,当患者选择适当时,腺苷可能是治疗阵发性室上性心动过速的最佳可用药物,尤其是在紧急情况下。

相似文献

1
Adenosine in the treatment of supraventricular tachycardia: 5 years of experience (2002-2006).腺苷治疗室上性心动过速:5年经验(2002 - 2006年)
Am J Emerg Med. 2008 Oct;26(8):879-82. doi: 10.1016/j.ajem.2007.11.029.
2
[Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].[使用腺苷终止室上性心动过速——比较12毫克和18毫克的有效性]
Dtsch Med Wochenschr. 2000 Aug 18;125(33):961-9. doi: 10.1055/s-2000-7002.
3
Efficacy of intravenous adenosine in treatment of paroxysmal supraventricular tachycardia in the local population.静脉注射腺苷治疗当地人群阵发性室上性心动过速的疗效。
Singapore Med J. 1997 Dec;38(12):525-8.
4
Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.在室上性心动过速的急诊治疗中,与静脉注射腺苷相比,钙通道阻滞剂的缓慢输注。
Resuscitation. 2009 May;80(5):523-8. doi: 10.1016/j.resuscitation.2009.01.017. Epub 2009 Mar 3.
5
Adenosine-induced ventricular fibrillation.腺苷诱发的心室颤动。
Indian Heart J. 2001 Mar-Apr;53(2):208-10.
6
Treatment of supraventricular tachycardia with adenosine in children: size does matter.腺苷治疗儿童室上性心动过速:剂量很重要。
Emerg Med J. 2009 Dec;26(12):911-2. doi: 10.1136/emj.2008.069252.
7
A prognostic index for the successful use of adenosine in patients with paroxysmal supraventricular tachycardia in emergency settings: a retrospective study.
Am J Emerg Med. 2008 Mar;26(3):304-9. doi: 10.1016/j.ajem.2007.05.034.
8
Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control.在没有医生直接指导的情况下,由急救医疗服务人员将静脉注射腺苷作为窄QRS波心动过速的院前一线治疗方法。
Am J Emerg Med. 1995 Jul;13(4):383-8. doi: 10.1016/0735-6757(95)90119-1.
9
[Adenosine for suppression of paroxysmal supraventricular tachycardia in a newborn infant. First case in Mexico].[腺苷用于抑制新生儿阵发性室上性心动过速。墨西哥首例病例]
Arch Inst Cardiol Mex. 1995 Mar-Apr;65(2):149-52.
10
Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department.腺苷在儿科急诊科治疗室上性心动过速中的应用。
Pediatr Emerg Care. 2014 Jun;30(6):388-93. doi: 10.1097/PEC.0000000000000144.

引用本文的文献

1
Exploring Treatment Protocol Adherence and Variations in Paroxysmal Supraventricular Tachycardia in the Emergency Department: A Multi-Center Cohort Study.急诊科阵发性室上性心动过速治疗方案的依从性及差异探索:一项多中心队列研究
Med Sci (Basel). 2025 May 9;13(2):58. doi: 10.3390/medsci13020058.
2
Safety of adenosine for pediatric tachyarrhythmia treatment in the emergency department: a multi-hospital 10-year cross-sectional study.急诊科使用腺苷治疗小儿快速性心律失常的安全性:一项多医院10年横断面研究。
Int J Emerg Med. 2024 Aug 30;17(1):103. doi: 10.1186/s12245-024-00683-5.
3
To decide medical therapy according to ECG criteria in patients with supraventricular tachycardia in emergency department: adenosine or diltiazem.
在急诊科根据心电图标准对室上性心动过速患者进行药物治疗:腺苷或地尔硫䓬。
Int J Clin Exp Med. 2015 Jun 15;8(6):9692-9. eCollection 2015.
4
Cardiac purinergic signalling in health and disease.健康与疾病中的心脏嘌呤能信号传导
Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20.
5
Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.儿科基础与高级生命支持:2010年国际心肺复苏与心血管急救科学及治疗建议共识。
Pediatrics. 2010 Nov;126(5):e1261-318. doi: 10.1542/peds.2010-2972A. Epub 2010 Oct 18.
6
Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.第十部分:儿科基础和高级生命支持:2010 年国际心肺复苏和紧急心血管急救科学共识及治疗推荐。
Circulation. 2010 Oct 19;122(16 Suppl 2):S466-515. doi: 10.1161/CIRCULATIONAHA.110.971093.
7
Carotid body function in aged rats: responses to hypoxia, ischemia, dopamine, and adenosine.老年大鼠的颈动脉体功能:对缺氧、缺血、多巴胺和腺苷的反应。
Age (Dordr). 2011 Sep;33(3):337-50. doi: 10.1007/s11357-010-9187-z. Epub 2010 Oct 5.